Dermatitis Clinical Trials in Chengdu, Sichuan
13 recruitingChengdu, Sichuan, China
Showing 1–13 of 13 trials
Recruiting
An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China
Atopic Dermatitis
AbbVie1,000 enrolled38 locationsNCT06421740
Recruiting
Phase 2
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Atopic Dermatitis
Pfizer340 enrolled98 locationsNCT05995964
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases
healthy adult participantsHealthy ParticipantsHealthy Volunteers+4 more
BeiGene211 enrolled13 locationsNCT06342713
Recruiting
Not Applicable
ROS-scavenging Amino Acid-derived Lipids for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer
Radiation Dermatitis
West China Hospital40 enrolled1 locationNCT07081074
Recruiting
Not Applicable
ROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer
Radiation Dermatitis
West China Hospital5 enrolled1 locationNCT07086638
Recruiting
Phase 3
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
AbbVie675 enrolled148 locationsNCT06461897
Recruiting
Phase 2Phase 3
Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis
Radiation induced dermatitis
West China Hospital60 enrolled2 locationsNCT07353671
Recruiting
Phase 1
A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects
Dermatitis
Suzhou Suncadia Biopharmaceuticals Co., Ltd.40 enrolled1 locationNCT07414602
Recruiting
Phase 2
A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis
Atopic Dermatitis
Chengdu Zenitar Biomedical Technology Co., Ltd111 enrolled1 locationNCT07193589
Recruiting
Phase 3
ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Beijing InnoCare Pharma Tech Co., Ltd.552 enrolled62 locationsNCT06775860
Recruiting
Not Applicable
Novel ROS-scavenging Nanoenzymes for the Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer
Radiation Dermatitis
West China Hospital30 enrolled1 locationNCT07064577
Recruiting
Not Applicable
AI App for Management of Atopic Dermatitis
Artificial IntelligenceAtopic Dermatitis
West China Hospital232 enrolled1 locationNCT06362629
Recruiting
Phase 3
A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Akeso420 enrolled59 locationsNCT06383468